We are live on
!
Find out more
LNAI
Lunai Bioworks
LNAI
LNAI
37 hedge funds and large institutions have $3.73M invested in Lunai Bioworks in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
0% less ownership
Funds ownership: 0.09% → 0.09% (-0%)
12% less funds holding
Funds holding: 42 → 37 (-5)
45% less capital invested
Capital invested by funds: $6.83M → $3.73M (-$3.1M)
52% less call options, than puts
Call options by funds: $13K | Put options by funds: $27K
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
37
Holders Change
-5
Holders Change %
-11.9%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
14
Reduced
11
Closed
7
Calls
$13K
Puts
$27K
Net Calls
-$14K
Net Calls Change
-$124K
Top Buyers
| 1 |
BlackRock
New York
|
+$58.5K |
| 2 |
Belvedere Trading
Chicago,
Illinois
|
+$39.6K |
| 3 |
Millennium Management
New York
|
+$32.9K |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$23.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$19.6K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$130K |
| 2 |
Two Sigma Investments
New York
|
-$84.4K |
| 3 |
Two Sigma Advisers
New York
|
-$55.6K |
| 4 |
Rafferty Asset Management
New York
|
-$48K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$28K |
